Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial ResultsGlobeNewsWire • Friday
Bellerophon Therapeutics (BLPH) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • Tuesday
Here's Why Momentum in Bellerophon Therapeutics (BLPH) Should Keep goingZacks Investment Research • 03/10/23
Bellerophon Therapeutics Receives IND Clearance from China NMPA to Conduct Phase 3 Clinical Trial in China for INOpulse® in Fibrotic Interstitial Lung DiseaseGlobeNewsWire • 02/09/23
Bellerophon Therapeutics Announces Completion of Enrollment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung DiseaseGlobeNewsWire • 01/18/23
Bellerophon Therapeutics Announces License Agreement for the Commercialization of INOpulse® in Greater China with Baylor BioSciencesGlobeNewsWire • 01/05/23
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2022 Financial ResultsGlobeNewsWire • 11/14/22
Bellerophon Announces FDA Acceptance of Change to Ongoing Phase 3 REBUILD Study of INOpulse® for Treatment of Fibrotic Interstitial Lung DiseaseGlobeNewsWire • 09/27/22
Bellerophon Provides Clinical Program Update and Reports Second Quarter 2022 Financial ResultsGlobeNewsWire • 08/15/22
Bellerophon Announces Poster Presentation at Upcoming American Thoracic Society 2022 International ConferenceGlobeNewsWire • 05/12/22
Bellerophon Provides Clinical Program Update and Reports First Quarter 2022 Financial ResultsGlobeNewsWire • 05/11/22
Bellerophon Provides Clinical Program Update and Reports Full-Year 2021 Financial ResultsGlobeNewsWire • 03/31/22
Bellerophon Stock Surges After Positive Data From Sarcoidosis-Associated Pulmonary Hypertension TrialBenzinga • 12/17/21
Bellerophon Reports Positive Top-Line Data from Phase 2 Acute Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with SarcoidosisGlobeNewsWire • 12/17/21
Bellerophon Therapeutics (BLPH) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?Zacks Investment Research • 12/01/21
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2021 Financial ResultsGlobeNewsWire • 11/15/21
Bellerophon to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire • 09/07/21